Cholesterol depletion reversibly abolishes carbachol-evoked Ca 2+ release from inositol (1,4,5)-trisphosphate (IP 3 )-sensitive stores, without affecting the distribution of IP 3 receptors (IP 3 R) or endoplasmic reticulum, IP 3 formation or responses to photolysis of caged IP 3 . Receptors that stimulate cAMP formation do not alone evoke Ca 2+ signals, but they potentiate those evoked by carbachol. We show that these potentiated signals are entirely unaffected by cholesterol depletion and that, within individual cells, different IP 3 -sensitive Ca 2+ stores are released by carbachol alone and by carbachol combined with receptors that stimulate cAMP formation. We suggest that muscarinic acetylcholine receptors in lipid rafts deliver IP 3 at high concentration to associated IP 3 R, stimulating them to release Ca 2+ . Muscarinic receptors outside rafts are less closely associated with IP 3 R and provide insufficient local IP 3 to activate IP 3 R directly. These IP 3 R, probably type 2 IP 3 R within a discrete Ca 2+ store, are activated only when their sensitivity is increased by cAMP. Sensitization of IP 3 R by cAMP extends the effective range of signalling by phospholipase C, allowing muscarinic receptors that are otherwise ineffective to recruit additional IP 3 -sensitive Ca 2+ stores.
Introduction
Many cells respond to extracellular stimuli with an increase in intracellular free Ca 2+ concentration, [Ca 2+ ] i . The complex spatio-temporal organization of these Ca 2+ signals provides the versatility that allows them selectively to regulate many cellular processes (Berridge et al., 2000) . Inositol (1,4,5)-trisphosphate (IP 3 ), by stimulating Ca 2+ release from the endoplasmic reticulum (ER), provides a common link between receptors at the plasma membrane and cytoplasmic Ca 2+ signals. Diverse stimuli, via their receptors, stimulate phospholipase C (PLC) and so formation of IP 3 , which binds to IP 3 receptors (IP 3 R) causing Ca 2+ to leak into the cytosol (Foskett et al., 2007; Taylor and Tovey, 2010) .
Parathyroid hormone (PTH) stimulates adenylyl cyclase (AC) via G protein-coupled receptors (GPCR). The type 1 PTH receptor (PTHR1) has attracted most attention because it has essential roles in bone remodelling and plasma Ca 2+ homeostasis, and it is a target of drugs used to treat osteoporosis (Mannstadt et al., 1999) . PTHR1 can stimulate both AC and an increase in [Ca 2+ ] i , but the relationships between these events are complex (reviewed in Taylor and Tovey, 2012) . PTH invariably stimulates AC, but it can also stimulate PLC directly when the signalling proteins are expressed at high levels (Offermanns et al., 1996; Schwindinger et al., 1998; Taylor and Tovey, 2012) or when PTHR1 associates with the scaffold proteins, Na + -H + -exchanger regulatory factors (NHERF) (Wang et al., 2010) . Cyclic AMP (cAMP), via exchange protein activated by cAMP (epac) and the monomeric G protein Rap, can also stimulate PLCe (Schmidt et al., 2001) . We Tovey et al., 2008; Tovey et al., 2003) and others (Schwindinger et al., 1998) find that in HEK 293 cells stably expressing physiological levels of PTHR1 (HEK-PR1 cells), PTH stimulates AC, but it does not alone evoke an increase in [Ca 2+ ] i . However, PTH (or endogenous b 2 -adrenoceptors) potentiates the Ca 2+ signals evoked by receptors that stimulate PLC (Kurian et al., 2009; Tovey et al., 2008) . This effect of PTH is entirely mediated by cAMP, it requires activation of neither cAMP-dependent protein kinase (PKA) nor epacs, and it results from cAMP binding to IP 3 R directly or to a protein that tightly associates with IP 3 R (Tovey et al., 2008; Tovey et al., 2010) . Although cAMP increases the sensitivity of all three IP 3 R subtypes to IP 3 , in intact HEK-PR1 cells a specific association of IP 3 R2 and AC6, an 'AC-IP 3 R junction', allows AC to deliver cAMP directly and at high concentration to IP 3 R (Fig. 1A ) (Tovey et al., 2008) .
Lipid rafts are ordered regions of the plasma membrane in which the outer leaflet is enriched in cholesterol and sphingolipids (Simons and Toomre, 2000) . Many signalling proteins, including GPCRs, G proteins, ACs, IP 3 Rs and PLCs, associate with lipid rafts and are thereby organized into signalling complexes (Isshiki and Anderson, 1999; Ostrom and Insel, 2004; Simons and Toomre, 2000) . Disruption of lipid rafts by cholesterol depletion has been reported to inhibit IP 3 -evoked Ca 2+ release (Nagata et al., 2007; Singleton and Bourguignon, 2004; Weerth et al., 2007) and to disrupt selective regulation of AC6 and AC8 by store-operated Ca 2+ entry (Willoughby and Cooper, 2007) . Evidence that delivery of cAMP from AC6 to IP 3 R2 mediates the effects of PTH on IP 3 -evoked Ca 2+ signals in HEK-PR1 cells (Tovey et al., 2008) alongside reports that AC5/6 (Head et al., 2005; Ostrom et al., 2002; Willoughby and Cooper, 2007) and IP 3 R2 (Weerth et al., 2007) can associate with cholesterol-rich lipid rafts prompted us to examine the role of lipid rafts in signalling by PTH.
Results

Loss of cholesterol inhibits carbachol-evoked Ca
2+
release, but not its potentiation by PTH Carbachol (CCh), a stable analogue of acetylcholine that stimulates IP 3 formation via endogenous M 3 muscarinic receptors (M 3 R) (Luo et al., 2008) , evoked Ca 2+ release from the intracellular stores of HEK 293 cells . This IP 3 -evoked Ca 2+ release was potentiated by PTH in HEK-PR1 cells (Fig. 1B) , by isoproterenol, which stimulates endogenous b 2 -adrenoceptors (supplementary material Fig. S1A ) (Kurian et al., 2009) , or by high concentrations of a membranepermeant analogue of cAMP, 8-bromo-cAMP (8-Br-cAMP) (supplementary material Fig. S1B ). Neither PTH nor isoproterenol alone stimulated Ca 2+ release ( Fig. 1B and  supplementary material Fig. S1A ). These results are consistent with earlier work suggesting that AC6-IP 3 R2 junctions allow cAMP to be delivered directly to IP 3 R at high concentrations to cause an increase in their sensitivity to IP 3 (Tovey et al., 2008; Tovey et al., 2010) . Subsequent experiments assess whether cholesterol, an essential component of lipid rafts (Simons and Ikonen, 1997) , is required for this selective communication (Fig. 1A) .
Filipin-staining established that most cholesterol was in the plasma membrane and that exposure to b-methylcyclodextrin (bMCD, 2% w/v, 2 hours at 20˚C) caused loss of plasma membrane cholesterol without perturbing cell morphology (Fig. 1C,D) . Similar results were obtained with brief exposure (10 minutes) to bMCD (2% w/v) at 37˚C (supplementary material Fig. S2A-C) . In most experiments, the more prolonged (30 minutes to 2 hours) treatment at 20˚C was used because it was then easier to adjust incubation times to achieve effective cholesterol depletion without causing cellular damage. Pre-treatment of cells with bMCD at 20˚C massively attenuated the Ca 2+ release evoked by CCh in populations of HEK-PR1 cells (Fig. 1E) . The peak increase in [Ca 2+ ] i evoked by a maximal concentration of CCh (1 mM) was reduced by 80611% from 234622 nM to 51626 nM (Fig. 1F) . The sensitivity to CCh was not significantly affected: the pEC 50 (2logEC 50 , where EC 50 is the half-maximally effective concentration) was 4.3860.14 and 3.8861.07 for control and bMCD-treated cells, respectively (Fig. 1F) . CCh-evoked Ca 2+ release was similarly inhibited by brief treatment with bMCD (2% w/v, 10 minutes) at 37˚C (supplementary material Fig. S2D ). The effects of cholesterol depletion on CCh-evoked Ca 2+ -release were reversed by cholesterol repletion (Fig. 1G) .
Although loss of cholesterol almost abolished responses to CCh, it had no significant effect on the Ca 2+ signals evoked by subsequent addition of PTH ( Fig. 2A-C of cells ( Fig. 2E-H) . Pre-treatment with bMCD significantly reduced both the number of cells responding to CCh alone (to 6367%, Fig. 2G ) and the amplitude of the peak Ca 2+ signal (Fig. 2H) . Even in those cells that responded to CCh, the amplitude of the Ca 2+ signal was reduced from 350652 nM to 19167 nM. However, bMCD had no effect on the number of cells in which PTH potentiated CCh-evoked Ca 2+ signals (9861% of cells, Fig. 2G ) or the amplitude of the peak response to PTH (22968 nM and 278627 nM in control and bMCD-treated cells, respectively). It is important to recall that PTH evokes Ca 2+ signals only when cells are co-stimulated with CCh (Fig. 1B ), yet after bMCD-treatment many cells (37%) failed to respond to CCh alone, but almost all cells (98%) responded to CCh with PTH (Fig. 2G ). Many bMCD-treated cells therefore responded to PTH with CCh despite not responding to CCh alone.
Addition of ionomycin, a Ca 2+ ionophore, to cells in Ca 2+ -free HBS was used to define the amount of Ca 2+ within intracellular stores (Fig. 2E,F ). The results demonstrate that loss of cholesterol had no effect on the initial Ca 2+ content of the stores (Fig. 2H, red) , but their residual Ca 2+ content after stimulation with CCh and PTH was significantly greater in bMCD-treated cells (Fig. 2H) . We conclude that cholesterol (Fig. 3C,D ). Just as with PTH, therefore, many cells in which bMCD-treatment abolished responses to CCh alone responded normally to stimulation with CCh and isoproterenol. Furthermore, the residual Ca 2+ content of the intracellular stores after stimulation with CCh and isoproterenol was significantly larger in cells that had been depleted of cholesterol (Fig. 3D) .
Potentiation of CCh-evoked Ca 2+ signals by PTH and b 2 -adrenoceptors depends on their ability to deliver cAMP locally at high concentrations to associated IP 3 R (Fig. 1A) (Tovey et al., 2008) Maximal activation of endogenous M 3 R in HEK cells generates insufficient IP 3 to directly release all IP 3 -sensitive Ca 2+ stores (Tovey et al., 2008) (Figs 2, 3) . This is consistent with the EC 50 for CCh-evoked Ca 2+ -release and the K D of CCh binding to M 3 R (Burford et al., 1995) being similar. The lack of 'spare receptors' is an experimental advantage in that it allows use of saturating concentrations of CCh to evoke submaximal Ca 2+ signals similar to those evoked by physiological stimuli, but it requires sensitive methods to resolve CCh-stimulated IP 3 formation. We used a FRET-based IP 3 -biosensor to allow real-time recording of IP 3 levels in CCh-stimulated HEK-PR1 cells (see Materials and Methods and supplementary material Fig. S4 ). Results shown in Fig. 4A show that CCh (20 mM) evoked a rapid and sustained increase in cytosolic IP 3 concentration that was unaffected by subsequent addition of PTH (100 nM), but increased further when the CCh concentration was increased (1 mM). This confirms that PTH does not affect the intracellular concentration of IP 3 . Treatment with bMCD had no effect on the IP 3 signals evoked by CCh alone or CCh with PTH (Fig. 4A,B) .
We used photolysis of ciIP 3 (caged iIP 3 ) non-disruptively loaded into cells as ciIP 3 /PM [cell-permeant caged iIP 3 , D-2,3-Oisopropylidene-6-O-(2-nitro-4,5-dimethoxy)benzyl-myo-inositol 1,4,5-trisphosphate-hexakis(propionoxymethyl)ester] (Dakin and Li, 2007) to assess the effects of bMCD on the Ca 2+ signals evoked ] i (Fig. 4C ). The amplitudes of these Ca 2+ signals varied between cells (supplementary material Fig. S5 ), perhaps reflecting differences in loading and de-esterification of ciIP 3 /PM. However, in a large sample (n.400 cells), the response to iIP 3 was unaffected by treatment with bMCD ( Fig. 4C-E) . Neither the fraction of cells responding to photolysis of ciIP 3 (7567% and 7767% for control and bMCD-treated cells, respectively) nor the average amplitude of the increase in fluo-4 fluorescence (DF/F 0 , 3.5260.40 and 3.2260.26) was affected by bMCD.
Treatment with bMCD caused HEK-PR1 cells to become slightly more rounded ( Fig. 1C; Fig. 4F ), but there was no obvious redistribution of the ER and it remained associated with the plasma membrane (Fig. 4F) . Immunostaining for each of the three IP 3 R subtypes confirmed that their distributions, whether assessed by widefield microscopy or total internal reflection fluorescence microscopy (TIRFM), were also unaffected by cholesterol depletion (Fig. 4G and supplementary material Fig. S6) .
We conclude that selective inhibition of CCh-evoked Ca 2+ release by cholesterol depletion occurs under conditions where CCh-evoked increases in cytosolic IP 3 are unaffected (Fig. 4B) , intracellular Ca 2+ stores are intact (Fig. 2H) , IP 3 R respond normally to IP 3 ( Fig. 4C-E) and there are no obvious changes in the distribution of the ER (Fig. 4F) or IP 3 Rs ( Fig. 4G ; supplementary material Fig. S6 ). This suggests that for cells stimulated with CCh alone cholesterol depletion disrupts effective delivery of IP 3 to IP 3 R, yet it has no effect on IP 3 delivery to IP 3 R that respond in the presence of either cAMP or 8-Br-cAMP. (Fig. 1B) (Tovey et al., 2008) . How might loss of cholesterol disrupt delivery of IP 3 to IP 3 R when CCh alone is the stimulus without affecting IP 3 delivery when CCh is combined with activation of receptors that stimulate AC? The effect cannot simply result from sensitization of IP 3 R by cAMP counteracting inhibition of M 3 R coupling to PLC because there was no detectable inhibition of IP 3 production (Fig. 4A) , and inhibition of PLC with U73122 similarly inhibited responses to CCh alone or CCh with PTH (supplementary material Fig. S7 ). In most of our experiments, where cells were first stimulated with CCh before addition of PTH, there was more Ca 2+ in the intracellular stores at the time of PTH addition for cells treated with bMCD ( Fig. 2H; Fig. 3D ). We had therefore to consider whether the lack of effect of bMCD on responses to CCh with PTH might result from a fortuitous combination of a larger intracellular Ca 2+ pool together with PTH, via cAMP, increasing the sensitivity of IP 3 R (Tovey et al., 2008) . That explanation is unlikely because responses to every concentration of PTH were insensitive to bMCD (Fig. 2D) . We nevertheless assessed the proposal directly using a protocol that allowed the CCh-sensitive Ca 2+ stores to be depleted before treatment with bMCD and then stimulation with CCh and PTH.
Cells were first stimulated with CCh in nominally Ca 2+ -free HBS to deplete the stores that respond to CCh alone. They were then rapidly depleted of cholesterol by incubation with bMCD (2% w/v, 10 minutes, 37˚C, supplementary material Fig. S2 ) and then the effects of PTH with CCh on [Ca 2+ ] i were assessed. The results demonstrate that prior stimulation with CCh or bMCD massively attenuated the Ca 2+ signals evoked by subsequent addition of CCh, and combining the treatments almost abolished the response to CCh (Fig. 5A, black) . However, the increase in [Ca 2+ ] i evoked by CCh with PTH was entirely unaffected by any of the treatments. Prior depletion of the CCh-sensitive Ca stores, cholesterol depletion, or both together had no effect on the ability of PTH to potentiate the increase in [Ca 2+ ] i evoked by CCh (Fig. 5A, blue) . These results demonstrate that the Ca 2+ stores released by CCh alone and those released by CCh combined with PTH are functionally independent (Fig. 5B) . We conclude that M 3 R communicate with different IP 3 R in different Ca 2+ stores when cells are activated by CCh alone or by CCh with stimuli that increase cAMP. Cholesterol depletion distinguishes these two pathways, and although cAMP is delivered focally to IP 3 R when its production is stimulated by PTH (Tovey et al., 2008) globally applied 8-Br-cAMP has the same effect ( Fig. 3E and  supplementary material Fig. S1B ). The two pathways from M 3 R to IP 3 R are not, therefore, dependent on local delivery of cAMP, they must differ in how they deliver IP 3 to IP 3 R.
Discussion
Functionally distinct IP 3 -sensitive Ca 2+ stores respond independently to CCh alone or to CCh delivered with stimuli, like PTH, that activate AC (Fig. 5B) . Cholesterol depletion almost abolishes responses to CCh (Fig. 1) Fig. 2) , isoproterenol or 8-Br-cAMP (Fig. 3) . Responses to PTH with CCh are unchanged despite there being more Ca 2+ within the intracellular stores after cholesterol depletion (Fig. 2) , and they are unaffected by depletion of the Ca 2+ stores that respond to CCh alone (Fig. 5A) . These results establish that even when M 3 R are maximally activated, a population of M 3 R stimulates Ca 2+ release via IP 3 R from a store that is unaffected by cAMP or 8-BrcAMP. Because cAMP increases the sensitivity of all IP 3 R subtypes to IP 3 , we conclude that the IP 3 concentration to which these CCh-regulated IP 3 Rs are locally exposed must be sufficient to cause their maximal activation. Evidence that bMCD massively attenuates CCh-evoked Ca (Fig. 4) is consistent with such a spatially organized delivery of IP 3 to IP 3 R that is disrupted by cholesterol depletion (Fig. 5B, left) . Responses to CCh alone are attenuated by loss of IP 3 R1, but not of IP 3 R2 (Tovey et al., 2008) , suggesting that these locally activated IP 3 R are likely to be IP 3 R1 (or IP 3 R3). Depleting cells, probably the plasma membrane (Fig. 1C) , of cholesterol, disrupts communication between these M 3 R and IP 3 R (Fig. 1) . Lipid rafts are enriched in M 3 R, Gaq and PLCb, they associate with IP 3 R, and in many cells disrupting lipid rafts inhibits M 3 Revoked Ca 2+ signals (Gosens et al., 2007; Lockwich et al., 2000) . We propose that M 3 R within lipid rafts locally deliver saturating concentrations of IP 3 to closely associated IP 3 R (Fig. 5B, left) . The concentration-dependent effects of CCh must then come largely from all-or-nothing recruitment of these IP 3 R junctions rather than from graded recruitment of IP 3 R within a junction. The graded CCh signal is transduced into a digital recruitment of IP 3 R junctions. Cholesterol depletion disrupts lipid rafts and thereby the interactions between M 3 R and IP 3 R that facilitate focal delivery of IP 3 , so that diffusion and degradation of IP 3 rapidly reduce its concentration to below the threshold for IP 3 R activation, thereby abolishing the CCh-evoked Ca 2+ signals (Fig. 5B, left) .
A second population of M 3 R is unaffected by cholesterol depletion and less intimately associated with IP 3 R. Activation of these M 3 R provides insufficient IP 3 to activate IP 3 R directly, but these IP 3 R respond when they are co-stimulated with cAMP (Fig. 5B, right) . Previous work showed that loss of IP 3 R2 attenuated Ca 2+ signals evoked by CCh and PTH without affecting responses to CCh alone (Tovey et al., 2008) . This suggests that IP 3 R2 populate the Ca 2+ store from which CCh evokes Ca 2+ release only in the presence of cAMP (Fig. 5B,  right) .
We showed earlier that activation of M 3 R and P2Y receptors in single HEK cells evokes Ca 2+ release from functionally distinct IP 3 -sensitive stores , suggesting that IP 3 can be locally delivered to IP 3 R. HEK cells are well-suited to addressing this feature because even maximally activated M 3 R generate insufficient IP 3 to release Ca 2+ from all IP 3 -sensitive stores. Signalling from M 3 R to IP 3 R therefore remains focal even when M 3 R are fully activated. In most cells with larger numbers of receptors, maximal activation is likely to generate high 2+ stores respond to CCh alone (left) or CCh with PTH (right). We suggest that activation of M 3 R within lipid rafts delivers a saturating concentration of IP 3 to closely associated IP 3 R (probably IP 3 R1 or IP 3 R3) allowing their robust 'all-ornothing' activation. Graded responses to increasing concentrations of CCh result from recruitment of these digital junctions, rather than graded activity within each junction. Because each junction is either inactive or maximally activated, sensitization of IP 3 R within them by cAMP or 8-Br-cAMP has no effect on IP 3 -evoked Ca 2+ release. M 3 R outside lipid rafts are less intimately associated with IP 3 R. Stimulation of these M 3 R provides insufficient IP 3 to activate the more distant IP 3 R directly. cAMP focally directed from AC6 to IP 3 R2 in response to PTH (Tovey et al., 2008) , or 8-Br-cAMP delivered globally, both increase IP 3 R sensitivity and thereby bring these IP 3 R within the sensitivity range of the IP 3 provided by more distant M 3 R. Modulation of IP 3 R by cAMP extends the effective signalling range of PLC signalling pathways, allowing M 3 R that were ineffective in the absence of cAMP to trigger Ca 2+ release from a distinct store in the presence of cAMP.
concentrations of IP 3 that flood the cytosol and obscure spatial organization. HEK cells provide the experimental convenience of working with all M 3 R activated while retaining physiologically relevant spatial organization. This experimental opportunity allowed us to demonstrate that M 3 R in lipid rafts deliver IP 3 at high local concentration to associated IP 3 R (Fig. 5B, left) . Such digital communication is robust and analogous to the digital signalling we proposed for cAMP delivery from AC6 to IP 3 R2 (Fig. 1A ) (Tovey et al., 2008) . M 3 R outside lipid rafts are less intimately associated with IP 3 R and their activation fails to deliver enough IP 3 to activate IP 3 R directly. Cyclic AMP, by sensitizing IP 3 R (Tovey et al., 2008; Tovey et al., 2010) , extends the range over which these M 3 R can signal, allowing M 3 R that are otherwise ineffective to recruit additional IP 3 -sensitive Ca 2+ stores. We conclude that M 3 R can signal directly to IP 3 R via digital junctions or more loosely via IP 3 diffusing over longer distances. The latter is ineffective unless cAMP tunes IP 3 R sensitivity, effectively extending the range of action of IP 3 produced in response to these otherwise ineffective M 3 R.
Materials and Methods
Materials
Cell culture media, Lipofectamine 2000, Alexa-488 conjugated secondary antibodies, fluo-4/AM, fura-2/AM and Ca 2+ standard solutions for calibration of fura-2 fluorescence signals to [Ca 2+ ] i were from Life Technologies (Paisley, UK). Ionomycin and 8-bromo-cAMP (8-Br-cAMP) were from Merck Bioscience (Nottingham, UK). 1,2-bis(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic acid (BAPTA) was from Molekula (Gillingham, UK). U73122 was from Tocris (Bristol, UK). Foetal bovine serum, carbamylcholine chloride (CCh), poly-Llysine, b-methylcyclodextrin (bMCD), filipin and isoproterenol were from SigmaAldrich (Poole, UK). G418 was from ForMedium (Hunstanton, UK). Cholesterol (plant-derived) was from Avanti Polar Lipids Inc. (Alabaster, USA). A peptide comprising residues 1-34 of human PTH (hereafter described as PTH) was from Bachem (St. Helens, UK). Cell-permeant caged iIP 3 (ciIP 3 /PM) was from Sichem (Bremen, Germany). Inositol 1,4,5-trisphosphate (IP 3 ) was from Alexis Biochemicals (Nottingham, UK) and 3 H-IP 3 (681Gbq/mmol) was from Perkin Elmer (Cambridge, UK). Cell culture plastics and 96-well assay plates were from Greiner (Stonehouse, UK). Imaging dishes (35-mm diameter with a 7-mm glass insert) were from MatTek Corporation (Ashland, USA) or PAA laboratories (Yeovil, UK). VECTASHIELD mounting reagent was from Vector Laboratories (Peterborough, UK). A plasmid encoding a Ca 2+ -indicator protein targeted to the ER lumen, D1ER, was a gift from R. Tsien (San Diego, USA) (Palmer et al., 2004) . It was used to identify ER rather than to measure free [Ca 2+ ]. An affinitypurified polyclonal antibody against the C-terminal of IP 3 R1 has been described (Cardy et al., 1997) . D. Yule (University of Rochester, USA) provided affinitypurified antibodies to the N-(residues 320-338) and C-terminals (residues 2686-2702) of IP 3 R2 (Betzenhauser et al., 2009; Betzenhauser et al., 2008) . A monoclonal antibody against IP 3 R3 was from BD Transduction Laboratories (Oxford, UK). A polyclonal anti-GFP antibody was from Abcam (Cambridge, UK).
Cell culture and transfection HEK 293 and HEK 293 cells stably transfected with the human type 1 PTH receptor (HEK-PR1 cells) were cultured at 37˚C in Dulbecco's modified Eagle's medium/Ham's F12 with GlutaMAX TM -1, supplemented with foetal bovine serum (10%) and 800 mg/ml G418 (HEK-PR1 cells only) in a humidified atmosphere containing 95% air and 5% CO 2 . Medium was replaced every third day, and cells were passaged when they reached about 80% confluence. For experiments with cell populations, cells were seeded into 96-well plates (,2610 4 cells/well). For single-cell analyses, cells were seeded (1.2610 5 cells/well) onto either 35-mm imaging dishes with a 7-mm glass insert or 22-mm round glass coverslips, each pre-coated with 0.01% poly-L-lysine. Cells were grown for a further 2-3 days before experiments or transfection. The latter used Lipofectamine 2000 according to the manufacturer's instructions with 1 mg DNA/well for cells in 35-mm imaging dishes. (Tovey et al., 2008) . All experiments were performed at 20˚C in HBS, nominally Ca 2+ -free HBS or Ca 2+ -free HBS. HBS had the following composition: 135 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 11.6 mM HEPES, 11.5 mM glucose, pH 7.3; CaCl 2 was omitted from nominally Ca 2+ -free HBS; Ca 2+ -free HBS was supplemented with 10 mM BAPTA. Singlecell analyses of [Ca 2+ ] i in HEK 293/HEK-PR1 cells loaded with fura-2/AM (2 mM) were performed as previously reported (Tovey et al., 2003) . Fluorescence ratios were calibrated, after correction for background fluorescence, to [Ca 2+ ] i by reference to Ca 2+ -calibration solutions. To allow photolysis of ciIP 3 , HEK-PR1 cells were first incubated at 20˚C for 45 minutes in HBS containing ciIP 3 /PM (1 mM) (Dakin and Li, 2007; Smith and Parker, 2009 ) and then for 45 minutes with HBS containing fluo-4/AM (2 mM) and ciIP 3 /PM (1 mM). After at least 60 minutes (during which any treatments used to deplete cholesterol were applied), cells were used for single-cell imaging. Imaging dishes were mounted on the stage of an Olympus IX81 inverted fluorescence microscope (606 TIRF objective, numerical aperture 1.45). Excitation light was provided by a 488-nm diode-pumped solid-state laser (Olympus Digital Laser Systems, Milton Keynes, UK) and emitted fluorescence (500-550 nm) was captured with an eMCCD camera (Andor ixon 897, Andor, Belfast, UK). Two high-intensity flashes (,1 millisecond, 3000 mF, 300 V, ,170 J) from a JML-C2 xenon flash-lamp (Rapp OptoElectronic, Hamburg, Germany) equipped with a 395-nm barrier filter were used to photolyse ciIP 3 . Photolysis of ciIP 3 releases a form of IP 3 (iIP 3 ) in which the 2-and 3-hydroxyl groups are protected by an isopropylidene group. This does not prevent it from activating IP 3 R, but iIP 3 is more resistant than IP 3 to degradation by endogenous enzymes (Dakin and Li, 2007) . For these measurements of [Ca 2+ ] i using a nonratiometric indicator (fluo-4), responses are reported as F/F 0 , where F 0 is the average fluorescence intensity recorded from a defined region of interest (ROI) in the 5 seconds immediately before flash photolysis, and F is the fluorescence intensity from the same region after the flash.
Identification of endoplasmic reticulum and IP 3 receptors
Total internal reflection fluorescence microscopy (TIRFM) using an Olympus IX81 inverted microscope with a triple-line TIRF combiner and a 1506 TIRF objective (numerical aperture 1.45) was used to visualize the ER in HEK-PR1 cells expressing D1ER (Palmer et al., 2004) . Fluorescence of EYFP was excited using a 488-nm diode-pumped solid-state laser, with emitted fluorescence (500-550 nm) captured using an eMCCD camera (Andor ixon 897). Widefield images of D1ER were obtained by excitation at 504 nm, with emission collected at 530-570 nm.
Endogenous IP 3 R were immunostained as described (Tovey et al., 2001) , with all steps performed at 20˚C in phosphate-buffered saline (PBS) unless stated otherwise. Cells on 35-mm imaging dishes were washed, fixed with paraformaldehyde (4% w/v in PBS) for 30 minutes, washed again and permeabilized with Triton X-100 (0.2% v/v in PBS, 10 minutes). Cells were then incubated in blocking medium (3% w/v BSA in PBS) for 1 hour, then with primary antibody (1:100 in blocking medium) overnight at 4˚C, washed (3610 minutes), incubated with Alexa-Fluor-488 conjugated secondary antibody for 1 hour (1:1000 in blocking medium) and washed (3610 minutes). Immunofluorescence was imaged as described for D1ER. PBS had the following composition: 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.4.
Measurement of IP 3
Intracellular IP 3 was measured using a FRET-based IP 3 -sensor derived from the IP 3 -binding core (IBC) of IP 3 R1 tagged at its N-and C-termini with ECFP and EYFP, respectively, each attached by a short linker (supplementary material Fig.  S4A ). The sequence encoding residues 224-604 of IP 3 R1 was PCR-amplified from a full-length rat IP 3 R1(S1 + ) sequence (GenBank: GQ233032.1) using primers 1 and 2. The sequences of all primers are provided in supplementary material Table  S1 . The fragment was cloned as a BamHI/XhoI fragment into the pENTR1 vector (Gateway) to generate the construct pENTR1-IBC. The open reading frame (ORF) of ECFP was PCR-amplified from the pECFP-ER vector (Clontech) using primers 3 and 4 and cloned as a BamHI/MluI fragment into pENTR1-IBC to generate the construct pENTR1-ECFP-IBC. The ORF of EYFP was PCR-amplified from the pC1-EYFP vector (Clontech) using primers 3 and 5, and cloned as an EcoRI/XhoI fragment into pENTR1-ECFP-IBC to generate the construct pENTR1-ECFP-IBC-EYFP. The latter was inserted into the expression vector pcDNA3.2 (Gateway) to generate the IP 3 -sensor expression plasmid. Properties of the IP 3 -sensor are shown in supplementary material Fig. S4 .
Cells on 35-mm imaging dishes were transfected with the plasmid encoding the IP 3 -sensor (1 mg/dish) using Lipofectamine 2000, and used 2 days later. An Olympus IX81 inverted microscope equipped with a 606 TIRF objective (numerical aperture 1.45) and a 440/520 nm dual band-pass dichroic mirror was used to record fluorescence using widefield excitation at 427 nm and simultaneous collection of CFP (455-485 nm) and YFP (520-550 nm) emissions using an Olympus U-SIP split imaging TV port fitted with a 505-nm dichroic mirror (supplementary material Fig. S4E ). Split images were obtained at 1-second intervals using an eMCDD camera (Andor ixon 897). CFP and YFP emissions were background corrected and a normalized CFP/YFP ratio was calculated for each cell. IP 3 binding causes an increase in CFP/YFP ratio, indicative of decreased FRET (supplementary material Fig. S4D,E) . HEK cells transfected with the IP 3 -sensor in 6-well plates were washed, scraped into PBS containing protease inhibitors (1 tablet/10 ml, Roche Diagnostics, Mannheim, Germany) and centrifuged (650 g, 2 minutes). The pellet was lysed by two freeze-thaw cycles in liquid nitrogen, sonication (1 minute) and passage through a syringe needle. After centrifugation (12,000 g, 5 minutes), the supernatant was used for western blotting or 3 H-IP 3 binding. For blotting, proteins (50 mg) were loaded onto NuPAGE 4-12% Bis Tris gels (Life Technologies) and blotted with an anti-GFP antibody (1:1000). Equilibriumcompetition binding assays were performed as described (Rossi et al., 2009) . Briefly, incubations (500 ml) at 4˚C were performed in 50 mM Tris, 1 mM EDTA, pH 8.3 with 3 H-IP 3 (0.75 nM) and cell supernatant (150 mg protein). Reactions were terminated after 5 minutes by addition of poly(ethylene glycol) 8000 (500 ml, 30% w/v) and c-globulin (30 ml, 25 mg/ml) and centrifugation (20,000 g, 5 minutes). Radioactivity was determined by liquid scintillation counting. Nonspecific binding was determined by addition of 1 mM IP 3 .
Cholesterol depletion, repletion and measurement
After loading with a Ca 2+ indicator (and, where appropriate, ciIP 3 ), cells were depleted of intracellular cholesterol by incubation with bMCD (2% w/v, ,15 mM) for either 10 minutes at 37˚C or for up to 2 hours at 20˚C (Rodal et al., 1999; Sampson et al., 2004) . After washing, cells were used for experiments. Cholesterol was restored as a bMCD:cholesterol complex (10:1, 0.26% w/v (,2 mM) bMCD:200 mM cholesterol) added to cells for 1 hour at 37˚C. Briefly, a 100 mM solution of cholesterol was prepared in methanol:chloroform (2:1) and complexes of bMCD:cholesterol were formed by drop-wise addition of cholesterol to a continuously stirred (,2 hours) solution of 0.26% w/v bMCD in HBS maintained at 80˚C.
Free cholesterol was measured using filipin, a fluorescent antibiotic that binds to the free 3b-hydroxyl of cholesterol (McCabe and Berthiaume, 2001) . Cells were fixed with paraformaldehyde at 20˚C (4% w/v, 30 minutes), washed three times with PBS, and then with PBS containing glycine (1.5 mg/ml, 10 minutes) to terminate fixation. Cells were stained with filipin (50 mg/ml) in PBS containing foetal bovine serum (10%) for 2 hours at 20˚C, washed with PBS (3610 minutes), and mounted (VECTASHIELD). Filipin staining was visualized using an Olympus IX81 inverted fluorescence microscope with excitation at 380 nm and emission at 460-550 nm. Identical microscope and eMCCD camera settings were used to capture each image. The method used to quantify filipin staining is described in the legend to Fig. 1C .
Analysis
Concentration-effect relationships for each experiment were individually fitted to Hill equations using non-linear curve-fitting (GraphPad Prism, version 5) and the results obtained from each (pEC 50 , Hill coefficient h, maximal response) were pooled for statistical analysis and presentation. Student's t-test was used for statistical analyses. 
